Peter van Dam
0000-0002-9184-7703
11 papers found
Refreshing results…
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant
Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based study
The impact of the SARS-COV-2 pandemic on the quality of breast cancer care in EUSOMA-certified breast centres
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with Cancer
Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients
The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer
Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests
The art of obtaining a high yield of cell-free DNA from urine
Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform
Potential new biomarkers for squamous carcinoma of the uterine cervix
Missing publications? Search for publications with a matching author name.